1. Norbert Bischofberger, Ph.D. (President, Chief Executive Officer, and Director): Bischofberger joined Kronos Bio in 2018 after serving as the Chief Scientific Officer at Gilead Sciences. He has over 30 years of experience in the biotechnology industry.
2. Sandra A. Gardiner (Interim Chief Financial Officer): Gardiner has joined the leadership team with extensive experience in finance within the biotechnology sector.
3. Elena Ridloff (Director): Ridloff serves as a director at Kronos Bio.
4. Joshua Kazam (Director): Kazam serves as a director at Kronos Bio.
5. Katherine Vega Stultz (Director): Stultz serves as a director at Kronos Bio.
6. Roshawn Blunt (Director): Blunt serves as a director at Kronos Bio.
7. Taiyin Yang (Director): Yang serves as a director at Kronos Bio.
8. David Tanen (Director): Tanen serves as a director at Kronos Bio.
9. Arie Belldegrun (Chair of the Board of Directors): Belldegrun serves as the chair of the board at Kronos Bio.
10. Roger Dansey (Director): Dansey serves as a director at Kronos Bio.
11. Stephen Kelsey (Chief Medical Officer): Kelsey joined Kronos Bio in 2019 after serving as the Head of Early Development at AstraZeneca. He has over 20 years of experience in drug development.
12. Jim Bristol (Chief Business Officer): Bristol joined Kronos Bio in 2019 after serving as the Vice President of Business Development at Incyte Corporation. He has over 20 years of experience in business development and corporate strategy.
13. Alan Crane (Previous Chairman of the Board): Crane is a Partner at Polaris Partners and has over 20 years of experience in venture capital and private equity.
14. Nina Kjellson (Board Member): Kjellson is a General Partner at Canaan Partners and has over 20 years of experience in healthcare investing.
15. Beth Seidenberg (Board Member): Seidenberg is a Managing Director at Westlake Village BioPartners and has over 25 years of experience in the biotechnology industry.
16. Paul Hastings (Board Member): Hastings is a Partner at Y Combinator and has over 15 years of experience in start-up investing and entrepreneurship.,
Kronos Bio Inc currently has 74 employees.
News about Kronos Bio Inc Key Personnel |
In a move to propel its pipeline advancement and streamline operations, Kronos Bio Inc has recently implemented a new leadership structure. This restructuring includes the elimination of three executive officer roles and the appointment of a new Executive Leadership team. However, these strategic changes come at a time when the company has recorded a significant net loss and faces challenges in the Healthcare sector.
Facts:
Kronos Bio Inc reported a cumulative net loss of $-119 million during the 12 months ending in the third quarter of 2023. This financial setback has resulted in a concerning negative return on assets (ROA) of -48.26%. Such a negative ROA indicates that the company s asset...
|
